Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis
- PMID: 25113080
- DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.008
Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis
Abstract
Background: The dilemma of whether to treat mild strokes with tPA is a chronic problem. We performed a meta-analysis and metaregression of the published literature to determine the best definition of mild strokes and if intravenously administered tissue plasminogen activator (IV-tPA) is beneficial.
Methods: PubMed, Embase, Science Direct, and Cochrane CENTRAL were searched from inception to May 2013. The search terms used were "stroke," "cerebral infarct," "mild stroke," "minor stroke," "small infarct," "modified Rankin scale," "National Institutes of Health Stroke Scale (NIHSS) score," "stroke thrombolysis," and their combinations. Studies were included if they (1) involved 5 or more human patients with stroke; (2) analyzed modified Rankin scale (mRS) scores as the main variables of interest; (3) presented outcomes for NIHSS scores less than 6, 5, 4, or 3 points. Good outcomes were defined as mRS scores 0-1, and other outcomes studied were intracranial hemorrhage and mortality.
Results: Of 894 articles, 30 articles met our criteria. Only 8 articles provided patients arms with and without tPA treatment. A total of 637 patients with IV-tPA treatment and 568 without thrombolysis were included in analysis. Good outcomes were associated with tPA and just reached statistical significance (pooled odds ratio [OR], 1.319; 95% confidence interval [CI], 1.004-1.733; z = 1.987; P = .047). There were moderate levels of heterogeneity between studies (τ(2) = .346; Q = 19.974; df = 7; P = .006; I(2) = 64.954). On metaregression of a-priori sources of heterogeneity within individuals, we found age (B = -.37; z = -2.496; P = .012) to be a significant moderator. Mortality was not significantly different between IV-tPA-treated and nonthrombolyzed groups (pooled OR 1.095; 95% CI, .438-2.738; z = .193; P = .847).
Conclusions: Patients with mild stroke may derive benefit from intravenous thrombolysis without a significant increase in mortality.
Keywords: Acute ischemic stroke; functional outcome; meta-analysis; mild stroke; minor stroke; stroke thrombolysis.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.J Stroke Cerebrovasc Dis. 2013 May;22(4):550-3. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.021. Epub 2013 Feb 21. J Stroke Cerebrovasc Dis. 2013. PMID: 23433783
-
Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.Drug Des Devel Ther. 2017 May 18;11:1559-1566. doi: 10.2147/DDDT.S133759. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28572721 Free PMC article.
-
Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1276-81. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.037. Epub 2015 Apr 20. J Stroke Cerebrovasc Dis. 2015. PMID: 25906938 Free PMC article.
-
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.
-
Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.Stroke Vasc Neurol. 2018 Jan 5;3(1):22-27. doi: 10.1136/svn-2017-000106. eCollection 2018 Mar. Stroke Vasc Neurol. 2018. PMID: 29600004 Free PMC article.
Cited by
-
Minor Non-Disabling Stroke Patients with Large Vessel Severe Stenosis or Occlusion Might Benefit from Thrombolysis.Brain Sci. 2021 Jul 19;11(7):945. doi: 10.3390/brainsci11070945. Brain Sci. 2021. PMID: 34356179 Free PMC article.
-
Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management.J Cent Nerv Syst Dis. 2025 Feb 12;17:11795735251314881. doi: 10.1177/11795735251314881. eCollection 2025. J Cent Nerv Syst Dis. 2025. PMID: 39944087 Free PMC article.
-
Efficacy and Safety of Mechanical Thrombectomy for Acute Mild Ischemic Stroke with Large Vessel Occlusion.Med Sci Monit. 2020 Jul 6;26:e926110. doi: 10.12659/MSM.926110. Med Sci Monit. 2020. PMID: 32628645 Free PMC article.
-
Reperfusion therapy for minor stroke: A systematic review and meta-analysis.Brain Behav. 2019 Oct;9(10):e01398. doi: 10.1002/brb3.1398. Epub 2019 Sep 18. Brain Behav. 2019. PMID: 31532082 Free PMC article.
-
Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome.PLoS One. 2020 Apr 24;15(4):e0231448. doi: 10.1371/journal.pone.0231448. eCollection 2020. PLoS One. 2020. PMID: 32330144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous